Published February 20, 2025
| Version v1
Journal article
Open
The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities
Authors/Creators
- 1. Clinic of Internal Diseases UMHATEM "N. I. Pirogov", Sofia, Bulgaria|Medical University - Sofia, Sofia, Bulgaria
- 2. Medical University - Sofia, Sofia, Bulgaria
- 3. Bulgarian Pharmaceutical Science Society, Sofia, Bulgaria
- 4. Bulgarian Pharmaceutical Union, Sofia, Bulgaria
- 5. Clinic of Internal Diseases UMHATEM "N. I. Pirogov", Sofia, Bulgaria
Description
The nuclear factor kappa B (NF-kB) signaling module is a complex and highly interconnected molecular network with important functions in all nucleated cells. Most chronic diseases caused by lifestyle factors appear to be related to inflammation. The NF-kB plays a major role in the pathogenesis of the inflammation and its intimate molecular mechanism. This transcription factor participates in the evolution of diabetes and its complications. In T1D (Type 1 Diabetes), proinflammatory cytokines such as interleukin-1β (IL-1β), tumor necrosis factor (TNF), and CD40L secreted by immune cells in islets induce the activation of NF-kB in β-cells through both canonical and noncanonical roads. NF-kB activation increases the expression of genes, including TNF-α, IL-1β, IL-6, MCP-1, and ICAM-1, that initiate and promote atherosclerosis. In particular, the severity and lethality of acute lung injury or acute respiratory distress syndrome (ALI/ARDS) caused by pneumonia or sepsis is primarily associated with an NF-kB-mediated "cytokine storm," in which massive polymorphonuclear (PMN) extravasation and the subsequent release of cytokines cause rapid deterioration due to widespread inflammation and coagulation. Nuclear translocation of NF-kB p65 can induce the transcription of several genes involved in the induction of EMT (epithelial-to-mesenchymal transition). This has been confirmed in various types of cancer, including brain, breast, lung, and gastric cancer. Cutaneous T-cell lymphoma (CTCL) encompasses a group of lymphoproliferative disorders characterized by invasive neoplastic T cells in the skin and various clinical prognoses. In the early stages of CTCL, NF-kB activation and cell proliferation are stimulated by the autocrine production of TNFα, leading to increased NF-kB activation and resistance to apoptosis. Bladder cancer is the second most common genitourinary cancer and is often recurrent and/or chemoresistant after tumor resection. NF-kB is a transcription factor that plays a critical role in normal physiology and bladder cancer. Bladder cancer patients have pathologically active NF-kB induced by proinflammatory cytokines, chemokines, and hypoxia, enhancing carcinogenesis and progression of the disease.
Files
PHAR_article_146759.pdf
Files
(569.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6f9c58544cf03093c463bf2900eabdef
|
358.2 kB | Preview Download |
|
md5:757969ce0bdffca6024d1cbcb3f63c05
|
211.3 kB | Preview Download |
Additional details
References
- Abdin SM, Tolba MF, Zaher DM, Omar HA (2021) Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chemico-Biological Interactions 340: 109450. https://doi.org/10.1016/j.cbi.2021.109450
- Ahirwar DK, Mandhani A, Mittal RD (2010) IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Archives of Medical Research 41(2): 97–103. https://doi.org/10.1016/j.arcmed.2010.03.005
- Ahmed S, Mundhe N, Borgohain M, Chowdhury L, Kwatra M, Bolshette N, Ahmed A, Lahkar M (2016) Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan- Induced Diabetic Nephropathy. Inflammation 39(5): 1783–1797. https://doi.org/10.1007/s10753-016-0413-4
- Akbari M, Hassan-Zadeh V (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26(3): 685–698. https://doi.org/10.1007/s10787-018-0458-0
- Amstein LK, Ackermann J, Hannig J, Đikić I, Fulda S, Koch I (2022) Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis [published correction appears in PLoS Computational Biology 2023 Apr 14;19(4): e1011065. https://doi.org/10.1371/journal.pcbi.1011065]. PLoS Computational Biology 18(8): e1010383. [Published 2022 Aug 22] https://doi.org/10.1371/journal.pcbi.1010383
- Andreasen AS, Kelly M, Berg RM, Møller K, Pedersen BK (2011) Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PLoS ONE 6(9): e23999. https://doi.org/10.1371/journal.pone.0023999
- Arnold M, Morgan E, Rumgay H, Mafraa A, Singha D, Laversannea M, Vignata J, Gralowb JR, Cardosoc F, Sieslingd S, Soerjomatarama I (2022) Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66: 15–23. https://doi.org/10.1016/j.breast.2022.08.010
- Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234): 286–290. https://doi.org/10.1126/science.270.5234.286
- Barcelos IP, Troxell RM, Graves JS (2019) Mitochondrial Dysfunction and Multiple Sclerosis. Biology (Basel) 8(2): 37. [Published 2019 May 11] https://doi.org/10.3390/biology8020037
- Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R (2021) NF-κB: At the Borders of Autoimmunity and Inflammation. Frontiers in Immunology 12: 716469. [Published 2021 Aug 9] https://doi.org/10.3389/fimmu.2021.716469
- Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105(4): 1640–1647. https://doi.org/10.1182/blood-2004-06-2181
- Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Journal of Clinical Investigation 97(7): 1715–1722. https://doi.org/10.1172/JCI118598
- Braun FK, Al-Yacoub N, Plötz M, Möbs M, Sterry W, Eberle J (2012) Nonsteroidal anti- inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. Journal of Investigative Dermatology 132(2): 429–439. https://doi.org/10.1038/jid.2011.316
- Brüstle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM, Reardon C, Lacher SM, Ruland J, Ohashi PS, Mak TW (2012) The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Journal of Clinical Investigation 122(12): 4698–4709. https://doi.org/10.1172/JCI63528
- Cao X, Tian Y, Nguyen V, Zhang Y, Gao C, Yin R, Carver W, Fan D, Albrecht H, Cui T, Tan W (2021) Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice. The FASEB Journal 35(9): e21801. https://doi.org/10.1096/fj.202002742RR
- Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. National Academy of Sciences of the United States of America 111(6): 2247–2252. https://doi.org/10.1073/pnas.1322269111
- Chen BH, Hsieh CH, Tsai SY, Wang CY, Wang CC (2020) Anticancer effects of epigallocatechin- 3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. Scientific Reports 10(1): 5163. [Published 2020 Mar 20] https://doi.org/10.1038/s41598-020-62136-2
- Chen J, Cao X, Cui Y, Zeng G, Chen J, Zhang G (2018) Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Molecular Medicine Reports 17(3): 4011–4018. https://doi.org/10.3892/mmr.2017.8300
- Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6): 7204–7218. [Published 2017 Dec 14] https://doi.org/10.18632/Oncotarget23208
- Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P (2021) Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Frontiers in Immunology 12: 589095. [Published 2021 Apr 28] https://doi.org/10.3389/fimmu.2021.589095
- Cheng QJ, Ohta S, Sheu KM et al. (2021) NF-κB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages. Science 372(6548): 1349–1353. https://doi.org/10.1126/science.abc0269
- Cheng X, Wang F, Qiao Y, Chen T, Fan L, Shen X, Yu D, Huang Y, Wei M (2023) Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway. Chemico-Biological Interactions 370: 110295. https://doi.org/10.1016/j.cbi.2022.110295
- Chousterman BG, Swirski FK, Weber GF (2017) Cytokine storm and sepsis disease pathogenesis. Seminars in Immunopathology 39(5): 517–528. https://doi.org/10.1007/s00281-017-0639-8
- Christenson SA, Smith BM, Bafadhel M, Putcha N (2022) Chronic obstructive pulmonary disease. The Lancet 399(10342): 2227–2242. https://doi.org/10.1016/S0140-6736(22)00470-6
- Cowie MR, Fisher M (2020) SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nature Reviews Cardiology 17(12): 761–772. https://doi.org/10.1038/s41569-020-0406-8
- Daniels MA, Luera D, Teixeiro E (2023) NFκB signaling in T cell memory. Frontiers in Immunology 14: 1129191. [Published 2023 Feb 24] https://doi.org/10.3389/fimmu.2023.1129191
- DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodriguez C, Perlman S, Enjuanes L (2014) Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. Journal of Virology 88(2): 913–924. https://doi.org/10.1128/JVI.02576-13
- Deepak P, Axelrad JE, Ananthakrishnan AN (2019) The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases. Gastrointestinal Endoscopy Clinics of North America 29(3): 447–470. https://doi.org/10.1016/j.giec.2019.02.006
- DiDonato JA, Mercurio F, Karin M (2012) NF-κB and the link between inflammation and cancer. Immunological Reviews 246(1): 379–400. https://doi.org/10.1111/j.1600-065X.2012.01099.x
- Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature Reviews Endocrinology 5(4): 219–226. https://doi.org/10.1038/nrendo.2009.21
- Ettari R, Previti S, Bitto A, Grasso S, Zappalà M (2016) Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases. Current Medicinal Chemistry 23(12): 1217–1238.
- Fajgenbaum DC, June CH (2020) Cytokine Storm. The New England Journal of Medicine 383(23): 2255–2273. https://doi.org/10.1056/NEJMra2026131
- Forrester JV, Kuffova L, Delibegovic M (2020) The Role of Inflammation in Diabetic Retinopathy. Frontiers in Immunology 11: 583687. [Published 2020 Nov 6] https://doi.org/10.3389/fimmu.2020.583687
- Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V (2013) Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Digestive and Liver Disease 45(7): 543–551. https://doi.org/10.1016/j.dld.2012.11.010
- Freitas RHCN, Fraga CAM (2018) NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives. Current Drug Targets 19(16): 1933–1942. https://doi.org/10.2174/1389450119666180219120534
- Fritsch J, Abreu MT (2019) The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg? Gastrointestinal Endoscopy Clinics of North America 29(3): 381–393. https://doi.org/10.1016/j.giec.2019.02.005
- Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, H Sørensen T, Thomsen RW (2018) Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. Journal of Diabetes and its Complications 32(1): 34–40. https://doi.org/10.1016/j.jdiacomp.2017.09.010
- Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109: S81–S96. https://doi.org/10.1016/s0092-8674(02)00703-1
- Giridharan S, Srinivasan M (2018) Mechanisms of NF-κB p65 and strategies for therapeutic manipulation. Journal of Inflammation Research 11: 407–419. [Published 2018 Oct 30] https://doi.org/10.2147/JIR.S140188
- Grondona P, Bucher P, Schulze-Osthoff K, Hailfinger S, Schmitt A (2018) NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. Biomedicines 6(2): 38. [Published 2018 Mar 26] https://doi.org/10.3390/biomedicines6020038
- Hangai M, Yoshimura N, Yoshida M, Yabuuchi K, Honda Y (1995) Interleukin-1 gene expression in transient retinal ischemia in the rat. Investigative Ophthalmology & Visual Science 36(3): 571–578.
- Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacology 29(1): 91–100. https://doi.org/10.1007/s10787-020-00773-9
- Hayden MS, Ghosh S (2011) NF-κB in immunobiology. Cell Research 21(2): 223–244. https://doi.org/10.1038/cr.2011.13
- Hayden MS, Ghosh S (2012) NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes & Development 26(3): 203–234. https://doi.org/10.1101/gad.183434.111
- Heidenreich PA, Bozkurt B, Aguilar D et al. (2022) AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2022 May 3;145(18): e1033.] [published correction appears in Circulation. 2022 Sep 27;146(13): e185.] [published correction appears in Circulation. 2023 Apr 4;147(14): e674.]. Circulation 145(18): e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
- Isoda K, Young JL, Zirlik A et al. (2006) Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arteriosclerosis, Thrombosis, and Vascular Biology 26(3): 611–617. https://doi.org/10.1161/01.ATV.0000201938.78044.75
- Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 16(3): 438–440. https://doi.org/10.1096/fj.01-0707fje
- Janssen-Heininger YM, Poynter ME, Aesif SW, Pantano C, Ather JL, Reynaert NL, Ckless K, Anathy V, van der Velden J, Irvin CG, van der Vliet A (2009) Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proceedings of the American Thoracic Society 6(3): 249–255. https://doi.org/10.1513/pats.200806-054RM
- Jiang N, Chen XL, Yang HW, Ma YR (2015) Effects of nuclear factor κB expression on retinal neovascularization and apoptosis in a diabetic retinopathy rat model. International Journal of Ophthalmology 8(3): 448–452. [Published 2015 Jun 18] https://doi.org/10.3980/j.issn.2222-3959.2015.03.03
- Kaltschmidt C, Greiner JFW, Kaltschmidt B (2021) The Transcription Factor NF-κB in Stem Cells and Development. Cells 10(8): 2042. [Published 2021 Aug 10] https://doi.org/10.3390/cells10082042
- Kamat AM, Tharakan ST, Sung B, Aggarwal BB (2018) Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF- kappaB and upregulation of TRAIL receptors [published correction appears in Cancer Research 78(17): 5182. https://doi.org/10.1158/0008-5472.CAN-18-1825]. Cancer Research 69(23): 8958–8966. https://doi.org/10.1158/0008-5472.CAN-09-2045
- Kawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 13(11): 460–469. https://doi.org/10.1016/j.molmed.2007.09.002
- Ke G, Chen X, Liao R, Xu L, Zhang L, Zhang H, Kuang S, Du Y, Hu J, Lian Z, Dou C, Zhang Q, Zhao X, Zhang F, Zhu S, Ma J, Li Z, Li S, He C, Chen X, Wen Y, Feng Z, Zheng M, Lin T, Li R, Li B, Dong W, Chen Y, Wang W, Ye Z, Deng C, Xiao H, Xiao J, Liang X, Shi W, Liu S (2021) Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy. Kidney International 100(2): 377–390. https://doi.org/10.1016/j.kint.2021.04.036
- Kellogg RA, Tian C, Etzrodt M, Tay S (2017) Cellular Decision Making by Non-Integrative Processing of TLR Inputs. Cell Reports 19(1): 125–135. https://doi.org/10.1016/j.celrep.2017.03.027
- Kim SJ, Yoon DH, Kang HJ, Kimd JS, Parke SK, Kimf HJ, Leea J, Ryoob B-Y, Kog YH, Huhh J, Yangi WI, Kimj HK, Mink SK, Leel S-S, Dom I-G, Suhb C, Kim WS (2012) Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single- arm, phase 2 trial. European Journal of Cancer 48(17): 3223–3231. https://doi.org/10.1016/j.ejca.2012.06.003
- Kitada M, Zhang Z, Mima A, King GL (2010) Molecular mechanisms of diabetic vascular complications. Journal of Diabetes Investigation 1(3): 77–89. https://doi.org/10.1111/j.2040-1124.2010.00018.x
- Koerner L, Schmiel M, Yang TP, Peifer M, Buettner R, Pasparakis M (2023) NEMO- and RelA- dependent NF-κB signaling promotes small cell lung cancer. Cell Death & Differentiation 30(4): 938–951. https://doi.org/10.1038/s41418-023-01112-5
- Koide N, Kaneda A, Yokochi T, Umezawa K (2015) Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide. International Immunopharmacology 25(1): 162–168. https://doi.org/10.1016/j.intimp.2015.01.004
- Kong Q, Wang B, Zhong Y, Chen W, Sun J, Liu B, Dong J (2024) Modified Bushen Yiqi Formula mitigates pulmonary inflammation and airway remodeling by inhibiting neutrophils chemotaxis and IL17 signaling pathway in rats with COPD. Journal of Ethnopharmacology 321: 117497. https://doi.org/10.1016/j.jep.2023.117497
- Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. International Reviews of Immunology 30(1): 16–34. https://doi.org/10.3109/08830185.2010.529976
- Kunnumakkara AB, Shabnam B, Girisa S et al. (2020) Inflammation, NF-κB, and Chronic Diseases: How are They Linked? Critical Reviews in Immunology 40(1): 1–39. https://doi.org/10.1615/CritRevImmunol.2020033210
- Lakhdari O, Tap J, Béguet-Crespel F, Le Roux K, de Wouters T, Cultrone A, Nepelska M, Lefèvre F, Doré J, Blottière HM (2011) Identification of NF-κB modulation capabilities within human intestinal commensal bacteria. Journal of Biotechnology and Biomedicine 2011: 282356. https://doi.org/10.1155/2011/282356
- Lee KH, Ahn BS, Cha D, Jang WW, Choi E, Park S, Park JJ, Oh J, Jung DD, Park H, Park JJ, Suh Y, Jin D, Lee S, Jang Y-H, Yoon T, Park M-K, Seong Y, Pyo J, Yang S, Kwon Y, Jung H, Lim CC, Hong JJ, Park Y, Choi E, Shin JJ, Kronbichler A (2020) Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review. Autoimmunity Reviews 19(3): 102469. https://doi.org/10.1016/j.autrev.2020.102469
- Lee N, Heo YJ, Choi SE, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ (2021) Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways.Journal of Immunology Research 2021: 9944880. [Published 2021 Jun 2] https://doi.org/10.1155/2021/9944880
- Liang WJ, Yang HW, Liu HN, Qian W, Chen XL (2020) HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. Life Science 241: 117146. https://doi.org/10.1016/j.lfs.2019.117146
- Lin Z, Liao L, Zhao S, Gu W, Wang G, Shen Z, Wang Y, Chen K, Liu W, Cai Y, Wan C, Yan T (2023) Corylin inhibits the progression of Non-small cell lung cancer cells by regulating NF-κB signaling pathway via targeting p65. Phytomedicine 110: 154627. https://doi.org/10.1016/j.phymed.2022.154627
- Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy 2: 17023. https://doi.org/10.1038/sigtrans.2017.23
- Lu L, Zhu C, Xu J, Hu Y, Dai J, Wang S, Wei T (2024) Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke. International Journal of Chronic Obstructive Pulmonary Disease 19: 957–967. [Published 2024 Apr 18] https://doi.org/10.2147/COPD.S449521
- Luo KW, Wei Chen, Lung WY, Wei X-Y, Cheng B-H, Cai Z-M, Huang W-R (2017) EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9 [published correction appears in J Nutr Biochem. 2024 Jan;123: 109530.]. The Journal of Nutritional Biochemistry 41: 56–64. https://doi.org/10.1016/j.jnutbio.2016.12.004
- Luo KW, Zhu XH, Zhao T, Zhong J, Gao H-c, Lu X-L, Huang W-R (2020) EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway. Frontiers in Cell and Developmental Biology 8: 606123. [Published 2020 Dec 23] https://doi.org/10.3389/fcell.2020.606123
- Ma P, Luo Y, Zhu X, Ma H, Hu J, Tang S (2009) Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat. Biochemical and Biophysical Research Communications 380(2): 402–406. https://doi.org/10.1016/j.bbrc.2009.01.092
- MacNee W, Tuder RM (2009) New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proceedings of the American Thoracic Society 6(6): 527–531. https://doi.org/10.1513/pats.200905-027DS
- Magliano DJ, Boyko EJ (2023) IDF Diabetes Atlas 10th edition scientific committee . IDF Diabetes Atlas. 10th edn. Brussels: International Diabetes Federation; 2021.
- Matsumori A (2023) Nuclear factor-κB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease. European Cardiology Review 18: e40. [Published 2023 Jun 7] https://doi.org/10.15420/ecr.2023.10
- Matsumori A (2022) Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases. Global Heart 17(1): 80. [Published 2022 Nov 2] https://doi.org/10.5334/gh.1156
- Medeiros MC, Frasnelli SC, Bastos Ade S, Orrico SR, Rossa Jr C (2014) Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB. Journal of Applied Oral Science 22(3): 185–193. https://doi.org/10.1590/1678-775720130593
- Meyerovich K, Ortis F, Cardozo AK (2018) The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes. Journal of Molecular Endocrinology 61(2): F1–F6. https://doi.org/10.1530/JME-16-0183
- Michels da Silva D, Langer H, Graf T (2019) Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences 20(9): 2322. [Published 2019 May 10] https://doi.org/10.3390/ijms20092322
- Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V (2022) NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. Journal of Cellular Physiology 237(7): 2770–2795. https://doi.org/10.1002/jcp.30759
- Mukherjee N, Houston TJ, Cardenas E, Ghosh R (2015) To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded. Carcinogenesis 36(3): 299–306. https://doi.org/10.1093/carcin/bgu321
- Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Investigative Ophthalmology & Visual Science 48(9): 4342–4350. https://doi.org/10.1167/iovs.06-1473
- Nakanishi C, Toi M (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nature Reviews Cancer 5(4): 297–309. https://doi.org/10.1038/nrc1588
- Nan J, Du Y, Chen X, Bai Q, Wang Y, Zhang X, Zhu N, Zhang J, Hou J, Wang Q, Yang J (2014) TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers. Molecular Cancer Therapeutics 13(3): 617–629. https://doi.org/10.1158/1535-7163.MCT-13-0464
- Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu X-F, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL (2020) Colchicine in Patients with Chronic Coronary Disease. The New England Journal of Medicine 383(19): 1838–1847. https://doi.org/10.1056/NEJMoa2021372
- Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhausa M, PPoole-Wilson A, Coats AJS, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. The Lancet 353(9167): 1838–1842. https://doi.org/10.1016/S0140-6736(98)09286-1
- Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspectives in Biology 1(4): a000034. https://doi.org/10.1101/cshperspect.a000034
- Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-κB signaling pathways. Nature Immunology 12(8): 695–708. [Published 2011 Jul 19] https://doi.org/10.1038/ni.2065
- Patel S, Santani D (2009) Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacological Reports 61(4): 595–603. https://doi.org/10.1016/s1734-1140(09)70111-2
- Pavitra E, Kancharla J, Gupta VK, Prasad K, Sung JY, Kim J, Tej MB, Choi R, Lee J-H, Han Y-K, Raju GSR, Bhaskar LVKS, Huh YS. (2023) The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy. Biomedicine & Pharmacotherapy 163: 114822. https://doi.org/10.1016/j.biopha.2023.114822
- Pereira SS, Alvarez-Leite JI (2014) Low-Grade Inflammation, Obesity, and Diabetes. Current Obesity Reports 3(4): 422–431. https://doi.org/10.1007/s13679-014-0124-9
- Pulitzer M (2017) Cutaneous T-cell Lymphoma. Clinics in Laboratory Medicine 37(3): 527–546. https://doi.org/10.1016/j.cll.2017.06.006
- Qin J, Wang Y, Bai Y, Yang K, Mao Q, Lin Y, Kong D, Zheng X, Xie L (2012) Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB mediated matrix metalloproteinase-9 expression. Molecular Medicine Reports 6(5): 1040–1044. https://doi.org/10.3892/mmr.2012.1054
- Qin J, Xie LP, Zheng XY, Wang Y-B, Bai Y, Shen H-F, Li L-C, Dahiya R (2007) A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochemical and Biophysical Research Communications 354(4): 852–857. https://doi.org/10.1016/j.bbrc.2007.01.003
- Que D, Kuang F, Kang R, Tang D, Liu J (2023) ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. Scientific Reports 13(1): 1483. [Published 2023 Jan 27] https://doi.org/10.1038/s41598-023-28261-4
- Rasmi RR, Sakthivel KM, Guruvayoorappan C (2020) NF-κB inhibitors in treatment and prevention of lung cancer. Biomedicine & Pharmacotherapy 130: 110569. https://doi.org/10.1016/j.biopha.2020.110569
- Recovery Collaborative Group, Horby P,Lim WS, et al. (2021) Dexamethasone in Hospitalized Patients with Covid-19. The New England Journal of Medicine 384(8): 693–704. https://doi.org/10.1056/NEJMoa2021436
- Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, JCornel H, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine 377(12): 1119–1131. https://doi.org/10.1056/NEJMoa1707914
- Rieger-Fackeldey E, Hentschel R (2008) Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models. Journal of Perinatal Medicine. 36(5): 442–447. https://doi.org/10.1515/JPM.2008.065
- Rishi L, Dhiman R, Raje M, Majumdar S (2007) Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-kappaB. Biochimica et Biophysica Acta 1770(8): 1230–1239. https://doi.org/10.1016/j.bbagen.2007.04.011
- Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C (2022) The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. Journal of Biological Chemistry 298(3): 101695. https://doi.org/10.1016/j.jbc.2022.101695
- Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46(5): 705–716. https://doi.org/10.1016/0092-8674(86)90346-6
- Sheu KM, Hoffmann A (2022) Functional Hallmarks of Healthy Macrophage Responses: Their Regulatory Basis and Disease Relevance. Annual Review of Immunology 40: 295–321. https://doi.org/10.1146/annurev-immunol-101320-031555
- Sors A, Jean-Louis F, Bégué E, Parmentier L, Dubertret L, Dreano M, Courtois G, Hervé Bachelez, Michel L (2008) Inhibition of IkappaB kinase subunit 2 in cutaneous T- cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clinical Cancer Research 14(3): 901–911. https://doi.org/10.1158/1078-0432.CCR-07-1419
- Sreenivasan Y, Sarkar A, Manna SK (2003) Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation. Oncogene 22(28): 4356–4369. https://doi.org/10.1038/sj.onc.1206486
- Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Progress in Retinal and Eye Research 30(5): 343–358. https://doi.org/10.1016/j.preteyeres.2011.05.002
- Tsai DH, Riediker M, Berchet A, Paccaud F, Waeber G, Vollenweider P, Bochud M. (2019) Effects of short- and long-term exposures to particulate matter on inflammatory marker levels in the general population. Environmental Science and Pollution Research 26(19): 19697–19704. https://doi.org/10.1007/s11356-019-05194-y
- Tun-Kyi A, Qin JZ, Oberholzer PA, Navarini AA, Hassel JC, Dummer R, Döbbeling U. (2008) Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Annals of Oncology 19(8): 1488–1494. https://doi.org/10.1093/annonc/mdn056
- Valencia JC, Egbukichi N, Erwin-Cohen RA (2019) Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity. Journal of Interferon & Cytokine Research 39(1): 72–84. https://doi.org/10.1089/jir.2018.0060
- Walter CEJ, Durairajan S, Periyandavan K et al. (2020) Bladder neoplasms and NF-κB: an unfathomed association. Expert Review of Molecular Diagnostics 20(5): 497–508. https://doi.org/10.1080/14737159.2020.1743688
- Wang J, Xu X, Elliott MH, Zhu M, Le YZ (2010) Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59(9): 2297–2305. https://doi.org/10.2337/db09-1420
- Wang MD, Li HT, Peng LX, Mei Y, Zheng L-S, Li C-Z, Meng D-F, Lang Y-H, Xu L, Peng X-S, Liu Z-J, Xie D-H, Guo L-L, Ma M-G, Ding L-Y, Huang B-J, Cao Y, Qian C-N (2024) TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer Gene Therapy 31(3): 454–463. https://doi.org/10.1038/s41417-023-00716-w
- Wang SY, Andrews CA, Herman WH, Gardner TW, Stein JD (2017) Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States. Ophthalmology 124(4): 424–430. https://doi.org/10.1016/j.ophtha.2016.10.031
- Wang X, Shen Y, MengLv L, Zhang XM, Yang J, Wang F, Yang J. (2020) Thalidomide suppresses breast cancer tumor growth by inhibiting tumor-associated macrophage accumulation in breast tumor-bearing mice. European Journal of Pharmaceutical Sciences 151: 105302. https://doi.org/10.1016/j.ejps.2020.105302
- Woo SL, Xu H, Li H, Zhao Y, Hu X, Zhao J, Guo X, Guo T, Botchlett R, Qi T, Pei Y, Zheng J, Xu Y, An X, Chen L, Chen L, Li Q, Xiao X, Huo Y, Wu C. (2014) Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. PLoS ONE 9(3): e91111. [Published 2014 Mar 17] https://doi.org/10.1371/journal.pone.0091111
- Yang F, Zeng F, Luo X, Lei Y, Li J, Lu S, Huang X, Lan Y, Liu R (2021) GLP-1 receptor: A new target for sepsis. Frontiers in Pharmacology 12: 706908. [Published 2021 Jul 14] https://doi.org/10.3389/fphar.2021.706908
- Ye X, Ding J, Zhou X, Chen G, Liu SF (2008) Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis [published correction appears in J Exp Med. 2008 Jun 9;205(6):1509]. Ournal of Experimental Medicine 205(6): 1303–1315. https://doi.org/10.1084/jem.20071393
- Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B, Yao L, Motaghi S, Couban RJ, Ghadimi M, Bala MM, Gomaa H, Fang FYX, Guyatt GH (2020) Efficacy and safety of corticosteroids in COVID- 19 based on evidence for COVID-19, other coronavirus infections, influenza, community- acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta- analysis. CMAJ 192(27): E756–E767. https://doi.org/10.1503/CMAJ200645
- Yi YW, You KS, Han S, Ha IJ, Park J-S, Lee S-G, Seong Y-S (2022) Inhibition of IκB kinase is a potential therapeutic strategy to circumvent resistance to epidermal growth factor receptor inhibition in triple-negative breast cancer cells. Cancers (Basel) 14(21): 5215. [Published 2022 Oct 24] https://doi.org/10.3390/cancers14215215
- Zamanian MY, Alsaab HO, Golmohammadi M, Yumashev A, Jabba AM, Abid MK, Joshi A, Alawadi AH, Jafer NS, Kianifar F, S Obakir B (2024) NF-κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation. Cell Biochemistry and Function 42(4): e4030. https://doi.org/10.1002/cbf.4030
- Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic M (2010) Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. Journal of Investigative Dermatology 130(8): 2110–2119. https://doi.org/10.1038/jid.2010.86
- Zhang Q, Lenardo MJ, Baltimore D (2017) 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell 168(1–2): 37–57. https://doi.org/10.1016/j.cell.2016.12.012
- Zhang X, Wu X, Hu Q, Wu J, Wang G, Hong Z, Ren J (2019) Mitochondrial DNA in liver inflammation and oxidative stress. Life Science 236: 116464. https://doi.org/10.1016/j.lfs.2019.05.020
- Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M (2007) Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. Journal of Clinical Oncology 25(27): 4293–4297. https://doi.org/10.1200/JCO.2007.11.4207